Dr. Mary-Claire Roghmann

powered by
COS Expertise®
University of Maryland at Baltimore
Medicine
Epidemiology and Preventive Medicine
Healthcare Outomes Research
Associate ProfessorAppointed: 2002
VA Maryland Health Care System
Hospital EpidemiologistAppointed: 1997
Professional Headshot of Mary-Claire Roghmann

Mailing Address

Division of Healthcare Outcomes Research
100 N. Greene St. (Lower Level)
Baltimore, Maryland 21201
United States

Contact Information

Phone: (410) 706-0062
Fax: (410) 706-0098
mroghman@epi.umaryland.edu

Qualifications

M.S., University of Maryland at Baltimore, Epidemiology and Preventive Medicine, 1997.
M.D., Johns Hopkins University, 1990.

Expertise and Research Interests

Dr. Mary-Claire Roghmann is an infectious disease physician and epidemiologist studying emerging pathogens and healthcare acquired infections. She received her M.D. from the Johns Hopkins University School of Medicine and her M.S. from the Department of Epidemiology and Preventive Medicine at the University of Maryland. Dr. Roghmann is an Associate Professor in the Department of Epidemiology and Preventive Medicine. She is also the Hospital Epidemiologist for the VA Maryland Health Care System.

Dr. Roghmann studies the epidemiology of antimicrobial-resistant pathogens such as methicillin-resistance S. aureus including risk factors for acquisition and infection and the impact on patients and the healthcare system. She has published over 50 papers and book chapters and mentored more than 20 faculty members, graduate students, fellows, residents and medical students. She has funding from the VA Research and Development and the Centers for Disease Control and Prevention (CDC) to study antibiotic resistance in the health care setting. Finally, she teaches clinical epidemiology as Education Director for the University of Maryland's General Clinical Research Center and on the Department of Epidemiology and Preventive Medicine's K30 grant.

Keywords

COS Keywords:

Antibiotics, Drug Resistance, Epidemiology, Infectious Diseases or Agents, Outcomes Research (Medical), Preventive Medicine.

Additional Terms:

Antibiotic Resistance, Nosocomial Infections.

Languages

(Reading, Writing, Speaking)

English: (Fluent, Fluent, Fluent)

Memberships

American College of Physicians
Infectious Diseases Society of America
Society for Healthcare Epidemiology of America

Previous Positions

2002-2007, Division Head, University of Maryland at Baltimore, Medicine, Epidemiology and Preventive Medicine, Healthcare Outomes Research
1997-2002, Assistant Professor, University of Maryland at Baltimore, Medicine, Epidemiology and Preventive Medicine, Healthcare Outomes Research

Funding Received

  • VA Research and Development Medical Research: Molecular Epidemiology of MRSA, $500,000, 2007 to 2011.
  • VA Research and Development Medical Research: Molecular Epidemiology of Antibiotic Resistance after Spinal Cord Injury, $420,000, 2003 to 2006.
  • Centers for Disease Control and Prevention Grant: The Clinical and Economic Impact of Antimicrobial Resistance on Nosocomial Infections in Intensive Care Units, $66,478, 2000 to 2002.
  • National Institutes of Health (NIH): Clinical Research Curriculum Award (K30), $921,546, 2000 to 2010.
  • VA Career Development Grant: The Epidemiology of Vancomycin-resistant Enterococcus (VRE), $117,300, 1998 to 2001.

Publications

  • Khanna N, Nesbitt L, Roghmann MC, Tacket C (Jun 2009) Translation of clinical research into practice: defining the clinician scientist., Family medicine, 41 (6), 440-3 Abstract
  • Shurland SM, Stine OC, Venezia RA, Johnson JK, Zhan M, Furuno JP, Miller RR, Johnson T, Roghmann MC (Apr 2009) Colonization sites of USA300 methicillin-resistant Staphylococcus aureus in residents of extended care facilities., Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America, 30 (4), 313-8 Abstract
  • Forrest GN, Roghmann MC, Toombs LS, Johnson JK, Weekes E, Lincalis DP, Venezia RA (Oct 2008) Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy., Antimicrobial agents and chemotherapy, 52 (10), 3558-63 Abstract
  • Snyder GM, Thom KA, Furuno JP, Perencevich EN, Roghmann MC, Strauss SM, Netzer G, Harris AD (Jul 2008) Detection of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci on the gowns and gloves of healthcare workers., Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America, 29 (7), 583-9 Abstract
  • Johnson JK, Khoie T, Shurland S, Kreisel K, Stine OC, Roghmann MC (Aug 2007) Skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus USA300 clone., Emerging infectious diseases, 13 (8), 1195-200 Abstract
  • Shurland S, Zhan M, Bradham DD, Roghmann MC (Mar 2007) Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus., Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America, 28 (3), 273-9 Abstract
  • Weber SG, Huang SS, Oriola S, Huskins WC, Noskin GA, Harriman K, Olmsted RN, Bonten M, Lundstrom T, Climo MW, Roghmann MC, Murphy CL, Karchmer TB (Mar 2007) Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: Position statement from the Joint SHEA and APIC Task Force., American journal of infection control, 35 (2), 73-85 Abstract
  • Roghmann MC, McGrail L (Oct 2006) Novel ways of preventing antibiotic-resistant infections: what might the future hold?, American journal of infection control, 34 (8), 469-75 Abstract
  • McGregor JC, Kim PW, Perencevich EN, Bradham DD, Furuno JP, Kaye KS, Fink JC, Langenberg P, Roghmann MC, Harris AD (Mar 2005) Utility of the Chronic Disease Score and Charlson Comorbidity Index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organisms., 161 (5), 483-93 Abstract
  • Kim PW, Perl TM, Keelaghan EF, Langenberg P, Perencevich EN, Harris AD, Song X, Roghmann MC (Mar 2005) Risk of mortality with a bloodstream infection is higher in the less severely ill at admission., 171 (6), 616-20 Abstract
  • Roghmann M, Taylor KL, Gupte A, Zhan M, Johnson JA, Cross A, Edelman R, Fattom AI (Jan 2005) Epidemiology of capsular and surface polysaccharide in Staphylococcus aureus infections complicated by bacteraemia., 59 (1), 27-32 Abstract

Profile Details

Last Updated: 7/23/2009

COS Expertise ID #835706
Reference this profile directly: http://myprofile.cos.com/mroghman